Universal Vision Biotechnology Co Ltd (3218) - Total Assets

Latest as of September 2025: NT$5.94 Billion TWD ≈ $187.12 Million USD

Based on the latest financial reports, Universal Vision Biotechnology Co Ltd (3218) holds total assets worth NT$5.94 Billion TWD (≈ $187.12 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Universal Vision Biotechnology Co Ltd for net asset value and shareholders' equity analysis.

Universal Vision Biotechnology Co Ltd - Total Assets Trend (2003–2024)

This chart illustrates how Universal Vision Biotechnology Co Ltd's total assets have evolved over time, based on quarterly financial data.

Universal Vision Biotechnology Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Universal Vision Biotechnology Co Ltd's total assets of NT$5.94 Billion consist of 49.3% current assets and 50.7% non-current assets.

Asset Category	Amount (TWD)	% of Total Assets
Cash & Equivalents	NT$0.00	8.8%
Accounts Receivable	NT$565.57 Million	9.8%
Inventory	NT$289.73 Million	5.0%
Property, Plant & Equipment	NT$0.00	0.0%
Intangible Assets	NT$0.00	0.0%
Goodwill	NT$0.00	0.0%

Asset Composition Trend (2003–2024)

This chart illustrates how Universal Vision Biotechnology Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Universal Vision Biotechnology Co Ltd.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Universal Vision Biotechnology Co Ltd's current assets represent 49.3% of total assets in 2024, an increase from 0.0% in 2003.
Cash Position: Cash and equivalents constituted 8.8% of total assets in 2024, down from 15.9% in 2003.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2003.
Asset Diversification: The largest asset category is accounts receivable at 9.8% of total assets.

Universal Vision Biotechnology Co Ltd Competitors by Total Assets

Key competitors of Universal Vision Biotechnology Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Meinian Onehealth Healthcare Holdings Co Ltd SHE:002044	China	CN¥19.57 Billion
Sanbo Hospital Management Group Ltd. A SHE:301293	China	CN¥3.72 Billion
Bait Bakfar Ltd TA:BKFR	Israel	ILA2.15 Billion
Pihlajalinna Oy HE:PIHLIS	Finland	€598.10 Million
Ramsay Health Care Ltd AU:RHC	Australia	AU$22.48 Billion
Regis Healthcare Ltd AU:REG	Australia	AU$2.11 Billion
Oceania Healthcare Ltd AU:OCA	Australia	AU$3.01 Billion
Pacific Smiles Group Ltd AU:PSQ	Australia	AU$163.53 Million

Universal Vision Biotechnology Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.46	2.05	2.18
Quick Ratio	2.17	1.85	2.10
Cash Ratio	0.00	0.00	0.00
Working Capital	NT$1.70 Billion	NT$1.51 Billion	NT$888.66 Million

Universal Vision Biotechnology Co Ltd - Advanced Valuation Insights

This section examines the relationship between Universal Vision Biotechnology Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	3.09
Latest Market Cap to Assets Ratio	0.06
Asset Growth Rate (YoY)	12.3%
Total Assets	NT$5.76 Billion
Market Capitalization	$353.68 Million USD

Valuation Analysis

Below Book Valuation: The market values Universal Vision Biotechnology Co Ltd's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Universal Vision Biotechnology Co Ltd's assets grew by 12.3% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Universal Vision Biotechnology Co Ltd (2003–2024)

The table below shows the annual total assets of Universal Vision Biotechnology Co Ltd from 2003 to 2024.

Year	Total Assets	Change
2024-12-31	NT$5.76 Billion ≈ $181.56 Million	+12.32%
2023-12-31	NT$5.13 Billion ≈ $161.64 Million	+13.87%
2022-12-31	NT$4.51 Billion ≈ $141.96 Million	+20.17%
2021-12-31	NT$3.75 Billion ≈ $118.13 Million	+18.32%
2020-12-31	NT$3.17 Billion ≈ $99.85 Million	+19.72%
2019-12-31	NT$2.65 Billion ≈ $83.40 Million	+26.25%
2018-12-31	NT$2.10 Billion ≈ $66.06 Million	+4.62%
2017-12-31	NT$2.00 Billion ≈ $63.15 Million	+15.01%
2016-12-31	NT$1.74 Billion ≈ $54.91 Million	-7.79%
2015-12-31	NT$1.89 Billion ≈ $59.54 Million	+4.84%
2014-12-31	NT$1.80 Billion ≈ $56.79 Million	+32.03%
2013-12-31	NT$1.37 Billion ≈ $43.02 Million	+8.65%
2012-12-31	NT$1.26 Billion ≈ $39.59 Million	-9.17%
2011-12-31	NT$1.38 Billion ≈ $43.59 Million	+36.86%
2010-12-31	NT$1.01 Billion ≈ $31.85 Million	-9.58%
2009-12-31	NT$1.12 Billion ≈ $35.22 Million	+2.57%
2008-12-31	NT$1.09 Billion ≈ $34.34 Million	+54.70%
2007-12-31	NT$704.59 Million ≈ $22.20 Million	+17.55%
2006-12-31	NT$599.41 Million ≈ $18.88 Million	+56.23%
2004-12-31	NT$383.68 Million ≈ $12.09 Million	+24.73%
2003-12-31	NT$307.60 Million ≈ $9.69 Million	--

About Universal Vision Biotechnology Co Ltd

TWO:3218 Taiwan Medical Care Facilities

Market Cap

$353.68 Million

NT$11.23 Billion TWD

Market Cap Rank

#14321 Global

#576 in Taiwan

Share Price

NT$132.50

Change (1 day)

-1.12%

52-Week Range

NT$123.50 - NT$218.50

All Time High

NT$655.60